{"id":"F2006L02514","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 30 of 2006)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-30-of-2006","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":59740,"registerId":"commonwealth-F2006L02514-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 30 of 2006)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85(2AA)\n\nNo. PB 30 OF 2006\n\nI, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:\n\n1. This Declaration commences on 1 August 2006.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nCimetidine Hydrochloride\n\nHydroxypropylcellulose\n\nLodoxamide Trometamol\n\nPolymyxin B Sulfate with Bacitracin Zinc and Neomycin Sulfate\n\nZalcitabine\n\nDated this 26th day of July 2006.\n\nJOAN CORBETT\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2982},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This declaration performs exactly the administrative function authorised by section 85(2AA) of the National Health Act 1953 - removing specific pharmaceutical benefits from PBS coverage. The scope is narrow and precisely matches the enabling power."},"complexity_factors":["Single operative clause removing specific named substances from the PBS","No conditional logic, exceptions, or nested provisions","Minimal cross-referencing (only cites the enabling Act section)","Short schedule listing only 5 chemical entities by name","Standard administrative declaration format with clear authority"],"plain_english_summary":"This declaration removes five specific medicines from Australia’s Pharmaceutical Benefits Scheme, ending government subsidies so patients will pay full commercial prices or seek alternatives.  \n\nAffected products include cimetidine, hydroxypropylcellulose, lodoxamide, a polymyxin–bacitracin–neomycin combination, and zalcitabine. The change matters because such delistings typically follow availability of newer or more cost‑effective options and can raise costs or force therapy changes for current users."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-30-of-2006","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-30-of-2006/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-30-of-2006/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-30-of-2006/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-30-of-2006/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-30-of-2006/documents"}}